ASAH1 and metastatic melanoma: Moreover, the expression of ASAH1 in tumors from metastatic melanoma patients, combined from public cohorts and classified according to our 3 previously defined scores, is lower in the transitory and dedifferentiation states when compared to the differentiated state (Figure 3A).